These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 10457374)
1. Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes. Ciccarelli R; Di Iorio P; Bruno V; Battaglia G; D'Alimonte I; D'Onofrio M; Nicoletti F; Caciagli F Glia; 1999 Sep; 27(3):275-81. PubMed ID: 10457374 [TBL] [Abstract][Full Text] [Related]
2. (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors. Thomsen C; Bruno V; Nicoletti F; Marinozzi M; Pellicciari R Mol Pharmacol; 1996 Jul; 50(1):6-9. PubMed ID: 8700119 [TBL] [Abstract][Full Text] [Related]
3. Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I- and II- selective metabotropic glutamate receptor agonists. Mistry R; Golding N; Challiss RA Br J Pharmacol; 1998 Feb; 123(3):581-9. PubMed ID: 9504400 [TBL] [Abstract][Full Text] [Related]
4. Activation of group II mGlu receptors inhibits voltage-gated Ca2+ currents in myenteric neurons. Chen WP; Kirchgessner AL Am J Physiol Gastrointest Liver Physiol; 2002 Dec; 283(6):G1282-9. PubMed ID: 12388194 [TBL] [Abstract][Full Text] [Related]
5. Opposite influence of the metabotropic glutamate receptor subtypes mGlu3 and -5 on astrocyte proliferation in culture. Ciccarelli R; Sureda FX; Casabona G; Di Iorio P; Caruso A; Spinella F; Condorelli DF; Nicoletti F; Caciagli F Glia; 1997 Dec; 21(4):390-8. PubMed ID: 9419014 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of metabotropic glutamate receptor-mediated high-affinity GTPase activity in rat cerebral cortical membranes. Nishi N; Odagaki Y; Koyama T Br J Pharmacol; 2000 Aug; 130(7):1664-70. PubMed ID: 10928972 [TBL] [Abstract][Full Text] [Related]
7. The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling. Bruno V; Sureda FX; Storto M; Casabona G; Caruso A; Knopfel T; Kuhn R; Nicoletti F J Neurosci; 1997 Mar; 17(6):1891-7. PubMed ID: 9045718 [TBL] [Abstract][Full Text] [Related]
8. Activator protein-1 responsive to the group II metabotropic glutamate receptor subtype in association with intracellular calcium in cultured rat cortical neurons. Sugiyama C; Nakamichi N; Ogura M; Honda E; Maeda S; Taniura H; Yoneda Y Neurochem Int; 2007 Dec; 51(8):467-75. PubMed ID: 17559977 [TBL] [Abstract][Full Text] [Related]
9. Interaction between A1 adenosine and class II metabotropic glutamate receptors in the regulation of purine and glutamate release from rat hippocampal slices. Di Iorio P; Battaglia G; Ciccarelli R; Ballerini P; Giuliani P; Poli A; Nicoletti F; Caciagli F J Neurochem; 1996 Jul; 67(1):302-9. PubMed ID: 8667006 [TBL] [Abstract][Full Text] [Related]
12. Metabotropic glutamate receptor agonists reduce glutamate release from cultured astrocytes. Ye ZC; Sontheimer H Glia; 1999 Feb; 25(3):270-81. PubMed ID: 9932873 [TBL] [Abstract][Full Text] [Related]
13. DCG-IV but not other group-II metabotropic receptor agonists induces microglial BDNF mRNA expression in the rat striatum. Correlation with neuronal injury. Venero JL; Santiago M; Tomás-Camardiel M; Matarredona ER; Cano J; Machado A Neuroscience; 2002; 113(4):857-69. PubMed ID: 12182892 [TBL] [Abstract][Full Text] [Related]
14. L-CCG-I activates group III metabotropic glutamate receptors in the hippocampal CA3 region. Kirschstein T; von der Brelie C; Steinhäuser M; Vinçon A; Beck H; Dietrich D Neuropharmacology; 2004 Aug; 47(2):157-62. PubMed ID: 15223294 [TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of group II metabotropic glutamate receptor agonist DCG-IV on hippocampal neurons in transient forebrain ischemia. Yoshioka H; Sugita M; Kinouchi H Neurosci Lett; 2009 Sep; 461(3):266-70. PubMed ID: 19549561 [TBL] [Abstract][Full Text] [Related]
16. Metabotropic glutamate receptor antagonists and agonists: potential neuroprotectors in diffuse brain injury. Fei Z; Zhang X; Bai HM; Jiang XF; Wang XL J Clin Neurosci; 2006 Dec; 13(10):1023-7. PubMed ID: 17113985 [TBL] [Abstract][Full Text] [Related]
17. (2R,1'S,2'R,3'S)-2-(2'-Carboxy-3'-phenylcyclopropyl)glycine (PCCG-13), the first potent and selective competitive antagonist of phospholipase D-coupled metabotropic glutamate receptors: asymmetric synthesis and preliminary biological properties. Pellicciari R; Marinozzi M; Costantino G; Natalini B; Moroni F; Pellegrini-Giampietro D J Med Chem; 1999 Jul; 42(14):2716-20. PubMed ID: 10411492 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological characterization of all sixteen stereoisomers of 2-(2'-carboxy-3'-phenylcyclopropyl)glycine. Focus on (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a novel and selective group II metabotropic glutamate receptors antagonist. Pellicciari R; Marinozzi M; Natalini B; Costantino G; Luneia R; Giorgi G; Moroni F; Thomsen C J Med Chem; 1996 May; 39(11):2259-69. PubMed ID: 8667369 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR. Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090 [TBL] [Abstract][Full Text] [Related]
20. (2S,1'S,2'R,3'R)-2(2'-Carboxy-3'-hydroxymethylcyclopropyl)glycine-[3H], a potent and selective radioligand for labeling group 2 and 3 metabotropic glutamate receptors. Wheeler WJ; Clodfelter DK; Collado I; Kulanthaivel P; Pedregal C; Stoddard EA; Wright RA; Schoepp DD Bioorg Med Chem Lett; 2005 Jan; 15(2):349-51. PubMed ID: 15603952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]